A Novel Pseudogene Methylation Signature to Predict Temozolomide Outcome in Non-G-CIMP Glioblastomas.
Li B, Wang J, Liu F, Li R, Hu W, Etcheverry A, Aubry M, Mosser J, Yin A, Zhang X, Wu Y, Chen K, He Y, Wang L.
Li B, et al. Among authors: liu f.
J Oncol. 2022 Jun 6;2022:6345160. doi: 10.1155/2022/6345160. eCollection 2022.
J Oncol. 2022.
PMID: 35712126
Free PMC article.